About: G1 Therapeutics

Property	Value
dbo:abstract	G1 Therapeutics, Inc. is an American biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company specializes in developing and commercializing small molecule therapeutics for the treatment of patients with cancer. (en) G1 Therapeutics, Inc. — американская биофармацевтическая компания, со штаб-квартирой в Северной Каролине. Компания специализируется на разработке и коммерциализации низкомолекулярных терапевтических средств для лечения больных раком. (ru)
dbo:foundedBy	dbr:Norman_Sharpless
dbo:foundingYear	2008-01-01 (xsd:gYear)
dbo:industry	dbr:Pharmaceuticals
dbo:location	dbr:United_States dbr:North_Carolina
dbo:numberOfEmployees	125 (xsd:nonNegativeInteger)
dbo:product	dbr:Cosela
dbo:thumbnail	wiki-commons:Special:FilePath/G1-therapeutics.jpg?width=300
dbo:wikiPageExternalLink	http://investor.g1therapeutics.com/static-files/67d303da-1561-47df-8cd2-d20e851dbd64 https://jitc.bmj.com/content/jitc/8/2/e000847.full.pdf https://www.cosela.com/patient https://www.g1therapeutics.com/ https://www.reuters.com/companies/GTHX.OQ/key-developments https://www.nasdaq.com/market-activity/stocks/gthx https://www.clinicaltrials.gov/ct2/results%3Fcond=&term=&type=&rslt=&age_v=&gndr=&intr=&titles=&outc=&spons=G1+Therapeutics&lead=&id=&cntry=&state=&city=&dist=&locn=&rsub=&strd_s=&strd_e=&prcd_s=&prcd_e=&sfpd_s=&sfpd_e=&rfpd_s=&rfpd_e=&lupd_s=&lupd_e=&sort= https://link.springer.com/article/10.1007/s12325-020-01538-0 https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.33453 https://www.science.org/doi/10.1126/scitranslmed.aal3986 https://www.sec.gov/cgi-bin/browse-edgar%3Faction=getcompany&CIK=GTHX https://finance.yahoo.com/quote/GTHX%3Fp=GTHX
dbo:wikiPageID	66078547 (xsd:integer)
dbo:wikiPageLength	20807 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1100748224 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Carboplatin dbr:Prescription_Drug_User_Fee_Act dbr:National_Comprehensive_Cancer_Network dbr:New_Drug_Application dbr:Simcere_Pharmaceutical dbr:Priority_review dbr:Non-Small_Cell_Lung_Cancer dbr:Bladder_cancer dbr:Boehringer_Ingelheim dbr:Breast_cancer dbr:Pfizer dbr:Research_Triangle_Park dbr:United_States dbr:University_of_North_Carolina_at_Chapel_Hill dbc:Biotechnology_companies_of_the_United_States dbr:Colorectal_cancer dbr:Small_molecule dbr:Gemcitabine dbr:GlaxoSmithKline dbr:NASDAQ dbr:Small-cell_carcinoma dbr:Combination_therapy dbr:Triple-negative_breast_cancer dbr:Avelumab dbr:Trilaciclib dbr:Cosela dbr:Food_and_Drug_Administration dbr:Breakthrough_therapy dbr:Norman_Sharpless dbr:North_Carolina dbr:PPD,_Inc. dbr:Palbociclib dbr:AstraZeneca dbc:Biopharmaceutical_companies dbc:Companies_based_in_North_Carolina dbr:Chemotherapy dbr:Biopharmaceutical dbr:Ibrance dbr:Docetaxel dbr:Bone_marrow_suppression dbr:CDK_inhibitor dbr:Metastasis dbr:National_Cancer_Institute dbr:Metastatic_breast_cancer dbr:Neutropenia dbr:Expanded_access dbr:Selective_estrogen_receptor_degrader dbr:Pharmaceuticals dbr:Prophylactic dbr:Small_cell_lung_cancer dbr:Myelosuppression dbr:Safety_profile
dbp:founders	dbr:Norman_Sharpless
dbp:industry	dbr:Pharmaceuticals
dbp:keyPeople	Jack Bailey, CEO Terry Murdock, COO Jennifer Moses, CFO Raj Malik, M.D., CMO Andrew Perry, CCO Mark Avagliano, CBO (en)
dbp:location	dbr:United_States dbr:North_Carolina
dbp:logo	G1-therapeutics.jpg (en)
dbp:name	G1 Therapeutics (en)
dbp:numEmployees	125 (xsd:integer)
dbp:products	dbr:Cosela
dbp:tradedAs	NASDAQ:GTHX (en)
dbp:type	Public (en)
dbp:wikiPageUsesTemplate	dbt:Infobox_company dbt:Reflist dbt:Short_description dbt:Start_date_and_age dbt:URL dbt:Use_dmy_dates
dct:subject	dbc:Biotechnology_companies_of_the_United_States dbc:Biopharmaceutical_companies dbc:Companies_based_in_North_Carolina
rdf:type	owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 dbo:Organisation
rdfs:comment	G1 Therapeutics, Inc. is an American biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company specializes in developing and commercializing small molecule therapeutics for the treatment of patients with cancer. (en) G1 Therapeutics, Inc. — американская биофармацевтическая компания, со штаб-квартирой в Северной Каролине. Компания специализируется на разработке и коммерциализации низкомолекулярных терапевтических средств для лечения больных раком. (ru)
rdfs:label	G1 Therapeutics (en) G1 Therapeutics (ru)
owl:sameAs	wikidata:G1 Therapeutics dbpedia-fa:G1 Therapeutics dbpedia-ru:G1 Therapeutics http://sah.dbpedia.org/resource/G1_Therapeutics https://global.dbpedia.org/id/FSR2Y
prov:wasDerivedFrom	wikipedia-en:G1_Therapeutics?oldid=1100748224&ns=0
foaf:depiction	wiki-commons:Special:FilePath/G1-therapeutics.jpg
foaf:isPrimaryTopicOf	wikipedia-en:G1_Therapeutics
foaf:name	G1 Therapeutics (en)
is dbo:wikiPageWikiLink of	dbr:List_of_drugs_granted_breakthrough_therapy_designation dbr:Boehringer_Ingelheim dbr:Andrew_Witty dbr:Small-cell_carcinoma dbr:Norman_Sharpless dbr:Palbociclib dbr:CDK_inhibitor dbr:Selective_estrogen_receptor_degrader dbr:List_of_companies_of_the_United_States_by_state
is foaf:primaryTopic of	wikipedia-en:G1_Therapeutics